The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy.

Not that scientists even agree on whether viruses are alive or not. There's so much we don't know, including just what they ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

High-dose radiotherapy may paradoxically worsen cancer by promoting metastasis of tumors a recent study revealed, the South ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Carrie Buck was raped, labeled an “imbecile,” and sterilized by order of the state — all in the name of genetic progress.

Researchers engineered a new therapeutically enhanced, naturally derived particle for powerful gene therapies to tackle our ...

Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States ...

Cancer thrives by stealing nutrients. Tumors grow fast because they hijack the body’s resources—especially glucose and fatty ...

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...